The Rest Of Latin America Sterilization Equipment Market was valued at $81.8 Million in 2026 and projected to reach to $97.8 Million by 2031, representing a compound annual growth rate of 3.7%. Rest Of Latin America's sterilization equipment market is positioned for steady but measured growth through 2031, supported by gradual healthcare infrastructure development and increasing regulatory emphasis on infection prevention.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Rest Of Latin America's sterilization equipment market is experiencing steady expansion at 3.7% CAGR, growing from USD 81.8 million in 2026 to USD 97.8 million by 2031, driven by healthcare infrastructure modernization across the region.
The region's growing investment in hospital and clinic facilities is creating increased demand for sterilization technologies, as healthcare providers prioritize infection control and patient safety standards.
Rising number of surgical facilities and outpatient centers across Rest Of Latin America is accelerating adoption of advanced sterilization equipment, supporting market growth despite economic constraints.
At 3.7% CAGR, Rest Of Latin America's market grows slower than the global average of 7.3%, reflecting regional economic challenges and varied healthcare spending capabilities across countries.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | STERILIZATION CONSUMABLES & ACCESSORIES (Product & Service) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 7.3% from 2026 to 2031 |
| Largest Segment | STERILIZATION INSTRUMENTS (Product & Service) |
| Market Size Base Year (Billions) | ~USD 19.4 (2026) |
| Revenue Forecast (Billions) | ~USD 27.6 (2031) |
| Segments Covered | Product & Service, Type, Technology, End User |
4 segment dimensions are covered across the global market.
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| GEA GROUP | Germany | Public Company | Separation & Flow Technologies,Liquid & Power Technologies,Food & Health Technologies, |
| AZBIL CORPORATION | Japan | Public Company | Building Automation Business,Advanced Automation Business,Life Automation Business, |
| INNOPHOS HOLDINGS, INC. | United States | Private Company | Specialty phosphates for food and beverage,Chelated mineral ingredients and nutrition,Pharmaceutical and high-spec applications, |
| SOLVAY SA | Belgium | Public Company | Soda ash and sodium bicarbonate,Hydrogen peroxide,Precipitated and highly dispersible silica, |
| STERIS | Ireland | Public Company | Healthcare sterilization and washers (CSSD/sterile processing equipment),Endoscope reprocessing systems and related consumables,Operating room equipment and procedural environment solutions, |
| SOTERA HEALTH | United States | Public Company | Sterigenics (outsourced terminal sterilization and irradiation services),Nordion (Cobalt-60 and gamma irradiation systems),Nelson Labs (microbiological and analytical chemistry testing and advisory), |
| FORTIVE | United States | Public Company | Test, Measurement, and Condition Monitoring (FLUKE and related),EHS, Compliance, and Connected Worker (INDUSTRIAL SCIENTIFIC, INTELEX),Facility and Asset Lifecycle Software (ACCRUENT, SERVICECHANNEL, GORDIAN), |
| GETINGE AB | Sweden | Public Company | Acute Care Therapies (ECMO, ventilation, monitoring, ICU infrastructure, drainage, cardiothoracic and vascular surgery),Surgical Workflows (OR tables, lights, anesthesia, OR integration, sterile supply management, cleaning and sterilization),Life Science (biocontainment, terminal sterilization, sterile isolation, bioreactors, labware cleaning, vivarium), |
| SOLVENTUM | United States | Public Company | Medsurg,Dental Solutions,Health Information Systems, |
| CARDINAL HEALTH | United States | Public Company | Branded & Generic Pharmaceutical Distribution,Specialty Pharmaceutical & Manufacturer Services,Cardinal Health Branded Medical & Surgical Products, |
| STRYKER CORPORATION | United States | Public Company | Orthopaedics (joint replacement, trauma, extremities, Mako Shoulder),MedSurg equipment and patient handling,Neurotechnology and stroke/venous interventions, |
| MERCK KGAA | Germany | Public Company | Life Science (tools, reagents, bioprocessing, CDMO),Healthcare (prescription drugs and biopharmaceuticals),Electronics (semiconductor and display materials), |
| DE LAMA S.P.A | United States | Public Investment Firm | Static billboards and posters,Digital billboards,Transit and airport advertising, |
GEA GROUP is a German public company founded in 1881 that employs 19,670 people. It operates as a multinational industrial equipment and technology provider.
AZBIL CORPORATION is a Japanese public company established in 1906 with 9,170 employees. It operates in automation and control systems.
INNOPHOS HOLDINGS, INC. is a United States-based private company founded in 2004 with 1,485 employees. It manufactures specialty ingredients and additives.
SOLVAY SA is a Belgian public company founded in 1863 with 8,400 employees. It is a global chemical and advanced materials manufacturer.
STERIS is an Irish public company founded in 1985. It provides sterilization and contamination control solutions for healthcare and life sciences.
SOTERA HEALTH is a United States-based public company founded in 2015 with 3,000 employees. It offers sterilization and decontamination services for medical devices.
FORTIVE is a United States-based public company founded in 2015 with 10,000 employees. It operates as a diversified industrial technology conglomerate.
GETINGE AB is a Swedish public company founded in 1904 with 11,754 employees. It manufactures infection control and sterilization equipment for healthcare.
SOLVENTUM is a United States-based public company founded in 2023 with 20,584 employees. It operates as a diversified healthcare and industrial technology company.
CARDINAL HEALTH is a United States-based public company founded in 1979 with 55,392 employees. It is a major healthcare services and pharmaceutical distributor.
STRYKER CORPORATION is a United States-based public company founded in 1941 with 56,000 employees. It manufactures medical devices and surgical equipment.
MERCK KGAA is a German public company founded in 1668 with 59,077 employees. It operates as a global pharmaceutical, chemical, and life sciences company.
DE LAMA S.P.A is a United States-based public investment firm founded in 1902 with 3,500 employees. It operates in financial services and investment management.
Rest Of Latin America's sterilization equipment market is valued at USD 81.8 million in 2026 and is forecast to reach USD 97.8 million by 2031.
Rest Of Latin America's sterilization equipment market is expected to grow at a CAGR of 3.7% from 2026 to 2031.
Rest Of Latin America's market growth is driven by increasing surgical volumes, heightened infection control awareness, government healthcare investments, and expansion of private healthcare providers.
Rest Of Latin America faces challenges including cost constraints, regulatory fragmentation across countries, uneven healthcare infrastructure, and limited access to advanced technologies in rural areas.
Rest Of Latin America's 3.7% CAGR is lower than the global 7.3% CAGR, reflecting slower healthcare modernization and higher cost sensitivity in the region.
The objective of this study is to analyze key market dynamics, including drivers, opportunities, restraints, and challenges, as well as the strategies of major players. We aim to track developments across leading firms, including acquisitions, product launches, expansions, agreements, and partnerships. The competitive landscape of sterilization equipment will be examined by evaluating market players based on various parameters within the broader categories of business and product strategy. To estimate the market size, both top-down and bottom-up approaches were employed. Additionally, the market breakdown and data triangulation methods were used to estimate segment and subsegment sizes.
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were primarily industry experts from core and related industries, as well as preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations across all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.
The following is a breakdown of the primary respondents:

Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.
|
COMPANY NAME |
DESIGNATION |
|
STERIS (US) |
Sales Manager |
|
Getinge AB (Sweden) |
Product Manager |
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the sterilization equipment. These methods were also widely used to estimate the sizes of various subsegments of the market. The research methodology used to estimate the market size includes the following:

After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Sterilization is a process that removes microorganisms and other pathogens from an object or surface by treating it with chemicals or by subjecting it to high heat or radiation. Sterilization is an integral part of infection control procedures. Sterilization equipment is used to sterilize various products and supplies in end-user facilities, whereas consumables & accessories help monitor and simplify the sterilization process. Sterilization services help eliminate contamination arising from all forms of life and other biological agents (such as microbes, particulate matter, and pyrogen) by treating them with chemicals or subjecting them to high heat or radiation. Sterilization is commonly used in laboratories and food processing & healthcare industries to prevent the spread of infections and maintain safety regulations.
Key Stakeholders
Report Objectives
MarketsandMarkets offers the following customizations for this market report.
Country Information
Company Profiles
Product Analysis
Full forecast, segment splits, and company analysis for all Sterilization Equipment Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report